Concurrent Disorder Management Guidelines. Systematic Review.

Area of Science:

• Clinical Psychology
• Psychiatry
• Public Health

Background:

• Concurrent disorders involve co-occurring substance use and mental health conditions requiring integrated treatment.
• These complex conditions are frequently underdiagnosed and undertreated, necessitating high-quality clinical guidelines.
• Effective management strategies are crucial for improving patient outcomes in concurrent disorders.

Purpose of the Study:

• To systematically evaluate the quality of existing clinical management guidelines for adult concurrent disorders.
• To identify strengths and weaknesses in current guideline recommendations for concurrent disorders.
• To inform the development of improved guidelines for managing co-occurring conditions.

Main Methods:

• Conducted comprehensive literature searches across electronic databases, web, and gray literature.
• Included English-language clinical management guidelines for adult concurrent disorders published between 2000 and 2020.
• Assessed 24 identified guidelines using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument.

Main Results:

• Most assessed guidelines demonstrated acceptable quality standards.
• Only the National Institute for Health and Care Excellence (NICE) guidelines provided comprehensive information across all AGREE II domains.
• Guidelines generally supported combined treatments for individual disorders, but with limited evidence specific to concurrent disorders.

Conclusions:

• While most guidelines offer acceptable standards, significant gaps exist in their recommendations for concurrent disorders.
• NICE guidelines represent a higher standard for quality in this field.
• Further research and structured recommendations are needed to advance the field of concurrent disorders management, including treatment integration models and complexity staging.